Home
Leadership
Science
Data
Media
- News
- Videos
Partners
Contact

Third Annual Healthspan Extension Policy and Regulation Workshop

Home / Events / Third Annual Healthspan Extension Policy and Regulation Workshop

09Jan 2018 by Andrew Premovich

– Upcoming

Search for:

Recent Posts

Listen to our founder and CEO, Lewis Gruber discuss SIWA and 318H!
In The News: Supertrends
Press Release: SIWA Therapeutics Grows Leadership Team with Appointment of Gabriela Rossi, Ph.D.
In The News: Startup.info Interview
In The News: BIOSPACE

Archives

April 2021
October 2020
September 2020
June 2020
May 2020
March 2020
February 2020
September 2019
March 2019
April 2018
January 2018
June 2017
May 2017
October 2016

Categories

Events
In The News
News
Press Releases
Uncategorized

About Us

SIWA’s 318H monoclonal antibody targets a biomarker on cancer cells, senescent cells, and microbially-infected cells. Our initial focus is on gastrointestinal and related diseases that are eligible for FDA Fast-tracking. We expect to file our first IND in late 2021 jointly with a major institution in pancreatic cancer/cachexia. ***

Recent News

Listen to our founder and CEO, Lewis Gruber discuss SIWA and 318H!
In The News: Supertrends
Press Release: SIWA Therapeutics Grows Leadership Team with Appointment of Gabriela Rossi, Ph.D.

JOIN OUR MAILING LIST

Navigation

Home
Leadership
Science
Data
Media
- News
- Videos
Partners
Contact